カテゴリ： MarketLine, アメリカ, 企業調査

Amarantus Bioscience Holdings Inc：企業のM&A・事業提携・投資動向

◆英語タイトル：Amarantus Bioscience Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード：DATA904C1995
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：75
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD700 ⇒換算￥103,600見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD1,050 ⇒換算￥155,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Amarantus Bioscience Holdings Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Amarantus Bioscience Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Amarantus Bioscience Holdings Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Amarantus Bioscience Holdings Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Amarantus Bioscience Holdings Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Amarantus Bioscience Holdings Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Amarantus Bioscience Holdings Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Amarantus Bioscience Holdings Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Amarantus Bioscience Holdings Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 6
LIST OF TABLES 8
LIST OF FIGURES 8
TARGETS AND PARTNERS 9
MERGERS & ACQUISITIONS 10
Mergers and Acquisitions – Overview 10
Mergers and Acquisitions – Deal reports 11
CORPORATE VENTURING 19
Corporate Venturing – Overview 19
Corporate Venturing – Deal reports 20
PARTNERSHIP 22
Partnership – Overview 22
Partnership – Deal reports 23
CAPITAL RAISING 48
Capital Raising – Overview 48
Capital Raising – Deal reports 49
DIVESTMENTS 57
Divestments – Overview 57
Divestments – Deal reports 58
PRIVATE EQUITY & OWNERSHIP 61
Private Equity and Ownership – Overview 61
Private Equity and Ownership – Deal reports 62
APPENDIX 64
Contact Us 64
About MarketLine Financial Deals Database 64
Deal Definition and Methodology 66
About MarketLine 73

List of Tables
Table 1: Amarantus Bioscience Holdings Inc M&A volume and value trend (2014-YTD2018)
Table 2: Amarantus Bioscience Holdings Inc M&A activity by geography (2014-YTD2018)
Table 3: Amarantus Bioscience Holdings Inc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Amarantus Bioscience Holdings Inc corporate venturing by geography (2014-YTD2018)
Table 5: Amarantus Bioscience Holdings Inc partnership volume and value trend (2014-YTD2018)
Table 6: Amarantus Bioscience Holdings Inc partnership trend by key deal type (2014-YTD2018)
Table 7: Amarantus Bioscience Holdings Inc capital raising volume and value trend (2014-YTD2018)
Table 8: Amarantus Bioscience Holdings Inc capital raising by deal type (2014-YTD2018)
Table 9: Amarantus Bioscience Holdings Inc divestments volume and value trend (2014-YTD2018)
Table 10: Amarantus Bioscience Holdings Inc divestments activity by geography (2014-YTD2018)
Table 11: Amarantus Bioscience Holdings Inc private equity and ownership volume and value trend (2014-YTD2018)
Table 12: Amarantus Bioscience Holdings Inc private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Amarantus Bioscience Holdings Inc M&A volume and value trend (2014-YTD2018)
Figure 2: Amarantus Bioscience Holdings Inc M&A activity by geography (2014-YTD2018)
Figure 3: Amarantus Bioscience Holdings Inc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Amarantus Bioscience Holdings Inc corporate venturing by geography (2014-YTD2018)
Figure 5: Amarantus Bioscience Holdings Inc partnership volume and value trend (2014-YTD2018)
Figure 6: Amarantus Bioscience Holdings Inc partnership trend by key deal type (2014-YTD2018)
Figure 7: Amarantus Bioscience Holdings Inc capital raising volume and value trend (2014-YTD2018)
Figure 8: Amarantus Bioscience Holdings Inc capital raising by deal type (2014-YTD2018)
Figure 9: Amarantus Bioscience Holdings Inc divestments volume and value trend (2014-YTD2018)
Figure 10: Amarantus Bioscience Holdings Inc divestments by geography (2014-YTD2018)
Figure 11: Amarantus Bioscience Holdings Inc private equity and ownership volume and value trend (2014-YTD2018)
Figure 12: Amarantus Bioscience Holdings Inc private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Amarantus Bioscience Holdings Inc：企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Essential Energy Services Ltd (ESN)：石油・ガス：M&Aディール及び事業提携情報
    Summary Essential Energy Services Ltd (Essential Energy) is an oil and gas company that offers oilfield services. The company provides coil well services and tool services. Its services include coil tubing, fluid and nitrogen pumping, completion, abandonment, and downhole tools and equipment rental …
  • Cinemark Holdings Inc (CNK)：企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Croma-Pharma GmbH：医療機器：M&Aディール及び事業提携情報
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company that offers development and commercialization of drugs in the field of aesthetic dermatology. The company’s products include princess skincare, princess injectables, and princess lift products. Its princess skincare products compri …
  • ConCardis GmbH：企業の戦略・SWOT・財務情報
    ConCardis GmbH - Strategy, SWOT and Corporate Finance Report Summary ConCardis GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cepheid：企業の戦略的SWOT分析
    Cepheid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Triple-S Management Corp (GTS)：企業の財務・戦略的SWOT分析
    Triple-S Management Corp (GTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • CryoTherapeutics Gmbh-医療機器分野：企業M&A・提携分析
    Summary CryoTherapeutics GmbH (CryoTherapeutics) is a medical equipment company that offers systemic drug based approach in combination with a localised device-based therapy. The company’s proprietary cryotherapy system is used for the treatment of coronary artery disease that causes heart attacks. …
  • Nostra Terra Oil and Gas Company plc (NTOG)：企業の財務・戦略的SWOT分析
    Summary Nostra Terra Oil and Gas Company Plc (NTOG) is an oil and gas company. The company explores, produces, and develops oil and gas properties across the US. It holds interest in operating and non-operating working interests in its projects located in New Mexico, Permian Basin located in West Te …
  • ABM Industries Incorporated：企業の戦略・SWOT・財務分析
    ABM Industries Incorporated - Strategy, SWOT and Corporate Finance Report Summary ABM Industries Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Credit Saison Co., Ltd.
    Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Edison SpA (EDNR)：電力：M&Aディール及び事業提携情報
    Summary Edison SpA (Edison), a subsidiary of Electricite de France S.A., is an energy company that explores, produces, develops and sells natural gas and crude oil in the Mediterranean Basin. The company generates and sells electricity; and develops, stores, transports and sells gas in Italy. Edison …
  • Accuray Inc (ARAY)：製品パイプライン分析
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • Amphenol Corp (APH)：企業の財務・戦略的SWOT分析
    Amphenol Corp (APH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • TetraLogic Pharmaceuticals (TLOG)-製薬・医療分野：企業M&A・提携分析
    Summary TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The company’s clinical stage products include birinapant and SHAPE. Its birinapant is a small molecule therape …
  • ET Solar Group Corporation：電力：M&Aディール及び事業提携情報
    Summary ET Solar Group Corporation (ET Solar) is a provider of renewable energy equipment and services. The company produces a variety of photovoltaic (PV) modules based on global standards such as IEC, TUV, VDE, and UL. It also provides horizontally integrated project development; finance and inves …
  • American Axle & Manufacturing Holdings Inc (AXL)：企業の財務・戦略的SWOT分析
    American Axle & Manufacturing Holdings Inc (AXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Yuanta Financial Holding Co., Ltd.：企業の戦略・SWOT・財務情報
    Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Heidelberger Druckmaschinen AG：企業の戦略・SWOT・財務情報
    Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report Summary Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Infant Bacterial Therapeutics AB (IBT B)：製薬・医療：M&Aディール及び事業提携情報
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • Immunovia AB (IMMNOV)：企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆